Nuformix Income Statement

Financials in millions GBP. Fiscal year is October - September.

Millions GBP. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	-	-	-	-	0.05	0.2
Revenue Growth (YoY)	-	-	-	-	-74.43%	-63.45%
Cost of Revenue	-	-	-	0.93	0	0.06
Gross Profit	-	-	-	-0.93	0.05	0.13
Selling, General & Admin	0.63	0.66	0.51	-	1.32	1.51
Other Operating Expenses	-	-	3.14	-	-	-0
Total Operating Expenses	0.63	0.66	3.65	0	1.32	1.51
Operating Income	-0.63	-0.66	-3.65	-0.93	-1.27	-1.37
Interest Expense	-	-	-	-	-	-0
Total Non-Operating Income (Expense)	-	-	-	-	-	-0
Pretax Income	-0.63	-0.66	-3.65	-0.93	-1.27	-1.38
Provision for Income Taxes	-	-0.01	-0.01	-0.07	-0.16	-0.12
Net Income	-0.63	-0.65	-3.64	-0.86	-1.11	-1.25
Net Income to Common	-0.62	-0.65	-3.64	-0.86	-1.11	-1.25
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	2,005	1,631	787	719	598	581
Shares Outstanding (Diluted)	2,005	1,631	787	719	598	581
Shares Change (YoY)	22.90%	107.27%	9.38%	20.22%	3.07%	21.71%
EPS (Basic)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-0.62	-0.61	-0.33	-0.55	-1.35	-0.85
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-0.00	-0.00	-0.00	-0.00	-0.00	-0.00
Gross Margin	-	-	-	-	96.61%	68.14%
Operating Margin	-	-	-	-	-2540.54%	-701.96%
Profit Margin	-	-	-	-	-2217.99%	-641.01%
FCF Margin	-	-	-	-	-2691.33%	-432.51%
EBITDA	-0.63	-0.63	-3.62	-0.93	-1.23	-1.28
EBITDA Margin	-	-	-	-	-2466.59%	-654.37%
EBIT	-0.63	-0.66	-3.65	-0.93	-1.27	-1.37
EBIT Margin	-	-	-	-	-2540.54%	-701.96%
Effective Tax Rate	-	1.21%	0.15%	7.44%	12.70%	8.89%